These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16530609)

  • 41. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Insulin and arterial hypertension: the role of the kidney].
    Beauwens R
    Bull Mem Acad R Med Belg; 2005; 160(7-9):347-53; discussion 353-5. PubMed ID: 16502970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant ENaC activation in Dahl salt-sensitive rats.
    Kakizoe Y; Kitamura K; Ko T; Wakida N; Maekawa A; Miyoshi T; Shiraishi N; Adachi M; Zhang Z; Masilamani S; Tomita K
    J Hypertens; 2009 Aug; 27(8):1679-89. PubMed ID: 19458538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood pressure effects of sodium transport along the distal nephron.
    Castañeda-Bueno M; Ellison DH
    Kidney Int; 2022 Dec; 102(6):1247-1258. PubMed ID: 36228680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dynamic interactions between integrative physiology and molecular medicine: the key to understand the mechanism of action of aldosterone in the kidney.
    Halperin ML; Kamel KS
    Can J Physiol Pharmacol; 2000 Aug; 78(8):587-94. PubMed ID: 10958158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of renal sodium transporters during severe inflammation.
    Schmidt C; Höcherl K; Schweda F; Kurtz A; Bucher M
    J Am Soc Nephrol; 2007 Apr; 18(4):1072-83. PubMed ID: 17314327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in renal sodium transport during hypertension development in ouabain-hypertensive rats].
    Ge H; Lü ZR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1404-7. PubMed ID: 17062336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular variants of the thiazide-sensitive Na+-Cl- cotransporter in hypertensive families.
    Keszei AP; Tislér A; Backx PH; Andrulis IL; Bull SB; Logan AG
    J Hypertens; 2007 Oct; 25(10):2074-81. PubMed ID: 17885550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aldosterone as an independent factor in cerebrovascular damage.
    Mulatero P; Caserta M; Bertello C; Schiavone D; Verhovez A; Giraudo G; Morello F; Veglio F
    Clin Exp Hypertens; 2008 Nov; 30(8):785-97. PubMed ID: 19021028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldosterone: Renal Action and Physiological Effects.
    Johnston JG; Welch AK; Cain BD; Sayeski PP; Gumz ML; Wingo CS
    Compr Physiol; 2023 Mar; 13(2):4409-4491. PubMed ID: 36994769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disorders of aldosterone synthesis, secretion, and cellular function.
    Root AW
    Curr Opin Pediatr; 2014 Aug; 26(4):480-6. PubMed ID: 24840884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The transport of sodium, water and active osmotic substances in different parts of the nephron of patients with chronic glomerulonephritis and hypertension].
    Gadaev A; Kaiukov IG; Ivakhniuk IS; Nikogosian IuA
    Klin Med (Mosk); 1992; 70(11-12):62-4. PubMed ID: 1294828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: a review of the relevant physiology.
    Rossi GM; Regolisti G; Peyronel F; Fiaccadori E
    J Nephrol; 2020 Jun; 33(3):431-445. PubMed ID: 31950375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocrine disorders of sodium regulation. Role of adrenal steroids in genetic defects causing sodium loss or sodium retention.
    Kuhnle U; Lewicka S; Fuller PJ
    Horm Res; 2004; 61(2):68-83. PubMed ID: 14646393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldosterone.
    Booth RE; Johnson JP; Stockand JD
    Adv Physiol Educ; 2002 Dec; 26(1-4):8-20. PubMed ID: 11850323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension.
    Adrogué HJ; Madias NE
    J Am Soc Hypertens; 2014 Mar; 8(3):203-13. PubMed ID: 24200471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetics of arterial hypertension and hypotension.
    Rosskopf D; Schürks M; Rimmbach C; Schäfers R
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):429-69. PubMed ID: 17262198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: implications on pathophysiology and drug discovery.
    Rossi GM; Regolisti G; Peyronel F; Fiaccadori E
    J Nephrol; 2020 Jun; 33(3):447-466. PubMed ID: 32060741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential role of serine proteases in modulating renal sodium transport in vivo.
    Jacquillet G; Rubera I; Unwin RJ
    Nephron Physiol; 2011; 119(2):p22-9. PubMed ID: 21832858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension?
    Rossier BC
    J Clin Invest; 2003 Apr; 111(7):947-50. PubMed ID: 12671041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.